Profil
Gregory Jones has worked as a Tax Director at Aerie Pharmaceuticals, Inc. since 2020.
Postes actifs de Gregory Jones
| Sociétés | Poste | Début |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 19/02/2020 |
Expériences
Fonctions occupées
Relations
52
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
